Public market insider buying at Neovasc (NVCN)

Public market insider buying at Neovasc (T:NVCN)

Doug Janzen, a Director, acquired 100,000 Common Shares on a direct ownership basis at a price of $0.870USD between June 21st, 2021 and June 22nd, 2021. This represents a $107,586 investment into the company's shares and an account share holdings change of greater than 100%.

Neovasc is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.

Neovasc Inc. is a Canada-based medical device company. The Company is developing, manufacturing and marketing products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, and Tiara (TM) for the transcatheter treatment of mitral valve disease. Neovasc Inc. (NVCN) has below median officer and director direct ownership compared to its small-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, one insider has invested a total amount of $107,586.